AI assistant
Sending…
Chemours Co — Director's Dealing 2020
Mar 5, 2020
31561_dirs_2020-03-04_73feb634-08f0-47b3-8d7e-fc4b071ebe2c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2020-03-02
Reporting Person: Kelliher Susan M. (SVP, People & Health Services)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-02 | Stock Option (Right to Buy) | $14.43 | A | 74866 | Acquired | 2030-03-02 | Common Stock (74866) | Direct |
Footnotes
F1: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021.
More from Chemours Co
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3